SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-11-001842
Filing Date
2011-08-12
Accepted
2011-08-12 17:28:21
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 amexdrug10q.txt 10-Q 55747
2 amexdrug10qexh311.txt EX-31 4247
3 amexdrug10qexh312.txt EX-31.2 4274
4 amexdrug10qexh321.txt EX-32.1 2084
5 amexdrug10qexh322.txt EX-32.2 2100
  Complete submission text file 0001096906-11-001842.txt   869855

Data Files

Seq Description Document Type Size
6 axrx-20110630.xml EX-101.INS 37039
7 axrx-20110630.xsd EX-101.SCH 9527
8 axrx-20110630_cal.xml EX-101.CAL 4560
9 axrx-20110630_def.xml EX-101.DEF 51971
10 axrx-20110630_lab.xml EX-101.LAB 91886
11 axrx-20110630_pre.xml EX-101.PRE 65748
Mailing Address 369 SOUTH DOHENY DR SUITE 326 BEVERLY HILLS CA 90211
Business Address 369 SOUTH DOHENY DR SUITE 326 BEVERLY HILLS CA 90211 3108550475
AMEXDRUG CORP (Filer) CIK: 0000045621 (see all company filings)

IRS No.: 952251025 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10304 | Film No.: 111032415
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries